Patents by Inventor Yoshio Kagitani

Yoshio Kagitani has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 4701325
    Abstract: An alkali metal hydrogensulfite or sulfite is effective for controlling a local injury such as inflammation and vein injury occurring on the injection of an antitumor benzodiazepine compound of the formula ##STR1## wherein R.sub.1 denotes hydrogen atom, or acyl, carbamyl, or alkoxycarbonyl group; R.sub.2 denotes hydrogen atom or acyl group; and R.sub.3 denotes sulfinic acid rest, SO.sub.2 X, or sulfonic acid rest, SO.sub.3 X, X meaning hydrogen, alkali metal or alkaline earth metal. An aqueous solution containing the both can be administered by injection.
    Type: Grant
    Filed: February 15, 1984
    Date of Patent: October 20, 1987
    Assignee: The Green Cross Corporation
    Inventors: Yasuo Ueda, Yoshio Kagitani, Shirou Komeda, Satoshi Funakoshi
  • Patent number: 4687762
    Abstract: The invention provides a method of producing a water-soluble complex comprising a water-insoluble drug and a phospholipid, comprising the steps of (1) dissolving a water-insoluble drug and a phospholipid in an organic solvent, (2) removing the solvent to leave behind a drug-containing phospholipid film, (3) suspending the resulting film in an aqueous solution, (4) ultrasonicating the film, (5) centrifuging the resulting suspension, and (6) recovering the lowermost layer of the resulting sediment to yield the water-soluble complex. The above complex can be administered parenterally as well as by the oral and other routes, and is so rich in the drug component that a remarkably increased drug activity can be realized.
    Type: Grant
    Filed: March 27, 1985
    Date of Patent: August 18, 1987
    Assignee: Green Cross Corporation
    Inventors: Tsunekazu Fukushima, Hiroshi Emoto, Yoshio Kagitani, Kazumasa Yokoyama, Masayuki Nishida, Tadakazu Suyama
  • Patent number: 4587052
    Abstract: Benzodiazepine derivative represented by the following general formula or pharmaceutically acceptable salt thereof: ##STR1## wherein R.sup.1 is --COR.sup.4 (R.sup.4 is a carboxylic acid residue) or an alkyl or aralkyl group (these groups have a substituent selected from a carboxyl group, an amino group and a cyano group), R.sup.2 is a lower alkyl group and R.sup.3 is a hydrogen atom or a lower alkyl group.The above compound is low in toxicity and has an antitumor activity.
    Type: Grant
    Filed: February 8, 1984
    Date of Patent: May 6, 1986
    Assignee: The Green Cross Corporation
    Inventors: Yasuo Ueda, Yusei Shiraga, Satoshi Morimoto, Yoshio Kagitani, Satoshi Funakoshi, Tadakazu Suyama
  • Patent number: 4587122
    Abstract: The drug such as antitumor agents or antibiotics can preferentially be carried to a morbid part, for example, injured tissue and tumor site by administering its complex with fibronectin combined through an oxidized dextran to repair the morbid part. The complex is prepared by reacting the drug, an oxidized dextran having a cleaved structure of aldohexopyranose ring, and fibronectin.
    Type: Grant
    Filed: April 23, 1985
    Date of Patent: May 6, 1986
    Assignee: The Green Cross Corporation
    Inventors: Yoshio Kagitani, Yasuo Ueda, Kozi Munechika, Satoshi Morimoto, Shirou Komeda, Kenji Tanaka, Kazumasa Yokoyama
  • Patent number: 4560556
    Abstract: Physiologically active substances such as antibiotics can preferentially be carried to a morbid part, for example, injured tissue and neoplastic cell proliferation site by administering its complex with fibronectin to repair the morbid part. The complex is prepared by the reaction between the physiologically active substance and the fibronectin with or without intervention of a protein cross-linking agent.
    Type: Grant
    Filed: January 23, 1984
    Date of Patent: December 24, 1985
    Assignee: The Green Cross Corporation
    Inventors: Yoshio Kagitani, Kenji Tanaka, Yasuo Ueda, Yusei Shiraga, Tunetaka Nakajima, Takuji Doi, Takao Ohmura, Satoshi Funakoshi, Tadakazu Suyama
  • Patent number: 4309437
    Abstract: Novel 5,10,11,11a-tetrahydro-8-methyl-11-sulfo or sulfino-1H-pyrrolo[2,1-c][1,4]-benzodiazepin-2-acrylamides which have antitumor activity and low toxicity are prepared by reacting corresponding 11-reactive compound with a reactive sulfur compound to form 11-sulfino compounds and, if desired, oxidizing the 11-sulfino compounds to obtain 11-sulfo compound.
    Type: Grant
    Filed: March 4, 1980
    Date of Patent: January 5, 1982
    Assignee: The Green Cross Corporation
    Inventors: Yasuo Ueda, Yoshio Kagitani, Eiji Sako, Tadakazu Suyama, Nobuhiko Komatsu, Daisuke Satoh
  • Patent number: 4265888
    Abstract: Acetylsalicylates with basic amino acids such as DL-lysine is stabilized in the form of solid preparation by admixing anhydrous calcium chloride therewith. The preparation containing calcium chloride is prevented from hydrolysis and can be stored for a long period of time even at a relatively high room temperature. The preparation is further prevented from discarolation when glycine is added thereto.
    Type: Grant
    Filed: January 8, 1980
    Date of Patent: May 5, 1981
    Assignee: The Green Cross Corporation
    Inventors: Yoshio Kagitani, Takashi Imagawa, Hirohisa Inahara, Ryozo Watanabe
  • Patent number: 4239683
    Abstract: Novel perhydro-1H-pyrrolo[2,1-C][1,4]benzodiazepin-5-one compounds having antitumor activity, perhydro-1H-pyrrolo[2,1-C][1,4]-benzodiazepin-5,11-dione, compounds which are synthetic intermediate of the former, and processes for producing these compounds.
    Type: Grant
    Filed: May 25, 1979
    Date of Patent: December 16, 1980
    Assignee: The Green Cross Corporation
    Inventors: Atuyuki Takanabe, Yoshio Arakawa, Yoshio Kagitani, Yasuo Ueda, Daisuke Satoh, Nobuhiko Komatsu
  • Patent number: 4185016
    Abstract: Novel perhydro-1H-pyrrolo[2,1-C][1,4]benzodiazepin-5-one compounds having antitumor activity, perhydro-1H-pyrrolo[2,1-C][1,4]-benzodiazepin-5,11-dione compounds which are synthetic intermediate of the former, and processes for producing these compounds.
    Type: Grant
    Filed: October 2, 1978
    Date of Patent: January 22, 1980
    Assignee: The Green Cross Corporation
    Inventors: Atuyuki Takanabe, Yoshio Arakawa, Yoshio Kagitani, Yasuo Ueda, Daisuke Satoh, Nobuhiko Komatsu